Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

10.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.7K
Blood Transfusion01:15

Blood Transfusion

487
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
487
Introduction to Hemostasis01:05

Introduction to Hemostasis

5.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.5K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

5.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

608
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
608
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

100
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
100

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Macroscale and microscale mechanical and biochemical properties of the equine superficial digital flexor tendon are regionally dependent.

American journal of veterinary research·2026
Same author

Influence of liquid repellency and slipperiness on blood-material interactions.

Journal of materials chemistry. B·2026
Same author

From saccharides to synthetics: exploring biomaterial scaffolds as cell transduction enhancers.

Biomaterials science·2025
Same author

Distinguishing the Metabolic Effect of Fetal and Adult Fibrinogen on Human Fibroblast Cell Culture by IR-MALDESI Mass Spectrometry Imaging.

Journal of the American Society for Mass Spectrometry·2025
Same author

Colloidal-fibrillar composite gels demonstrate structural reinforcement, secondary fibrillar alignment, and improved vascular healing outcomes.

Communications engineering·2025
Same author

Simple design for membrane-free microphysiological systems to model the blood-tissue barriers.

Organs-on-a-chip·2025

相关实验视频

Updated: Jun 5, 2025

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

9.3K

输血生物材料用于静血.

Ethan Pozy1, Ashley C Brown1

  • 1Joint Department of Biomedical Engineering of University of North Carolina, Chapel Hill and North Carolina State University, Raleigh, NC 27695, USA; Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27606, USA.

Journal of thrombosis and haemostasis : JTH
|December 15, 2024
PubMed
概括

合成注射性血静止剂为控制出血提供了输血的有希望的替代方案. 针对伤口部位的生物材料正在推进临床使用,改善静血治疗.

科学领域:

  • 生物材料科学 生物材料科学
  • 血液静止研究 血液静止研究
  • 药物输送系统 药物输送系统

背景情况:

  • 流血是创伤和手术中死亡的主要原因.
  • 传统的输血面临着后勤方面的挑战和捐献率的下降.
  • 生物材料为合成,可注射的血静止剂提供了潜力.

研究的目的:

  • 审查可注射血液静止生物材料的临床前研究.
  • 讨论目前的发现和血液静止技术的未来方向.
  • 探索针对性药物输送的进展,以控制出血.

主要方法:

  • 审查当前的临床前研究模型和研究结果.
  • 对脂质和聚合物颗粒进行血液静止分析.
  • 对聚合物平台的检查,这些聚合物平台与伤口连接物结合.

主要成果:

  • 生物材料,包括颗粒和平台,作为可注射的血静止剂显示出希望.
  • 这些技术准伤口部位并放大静血通路.
  • 临床前数据支持这些合成血静止剂的发展.

结论:

关键词:
生物相容的材料是生物相容的材料.血小板是血液中的血小板.血液静止 血液静止 血液静止纳米颗粒药物递送系统输血药物 输血药物是一种输血药物.

更多相关视频

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

783
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.7K

相关实验视频

Last Updated: Jun 5, 2025

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

9.3K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

783
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.7K
  • 可注射的静血生物材料代表了与传统方法相比的重大进步.
  • 对临床前模型的进一步研究对于临床转化至关重要.
  • 下一代生物材料血静止器正在接近临床应用.